October 2, 2018

https://www.prnewswire.com/news-releases/fda-grants-profounda-inc-competitive-generic-therapy-cgt-designation-for-planned-anda-filing-of-minocycline-hydrochloride-microspheres1-mg-300719797.html

October 22, 2017

https://youtu.be/5KK0HYPK57c

December 31, 2016

Sales of Impavido, Rhinase Soothing Nasal Gel and Rhinase Lubricating Mist exceeded $2.5 M for 2016 making it a great start for Profounda as it looks to introduce new products to the market in 2017.

December 31, 2016

Orphan indication received by Profounda is for the treatment of Acanthamoeba Keratitis, also commonly known as AK usually associated with contact lens wear.

ORLANDO, Fla. 

December 16, 2016

Orphan indication received by Profounda is for the treatment of PAM, also commonly known as the Brain Eating Amoeba

ORLANDO, Fla. 

Dec  15, 2016  Profounda, Inc. ("Profounda") announced today that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug...

September 12, 2016

http://www.clickorlando.com/news/broward-teen-survives-brain-eating-amoeba-was-treated-in-orlando

April 20, 2016

Profounda has received the necessary licensure from the State of Florida as a Drug Manufacturer which allows it to supply drug directly to those in need.

 

April 20, 2016

Impavido (miltefosine) is now available in the USA directly from Profounda for the treatment of leishmania.

Please reload

Featured Posts

http://www.clickorlando.com/news/broward-teen-survives-brain-eating-amoeba-was-treated-in-orlando

Patient survives Brain Eating Amoeba

September 12, 2016

1/3
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags